PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.
Yoshida H, Nomizo T, Ozasa H, Tsuji T, Funazo T, Yasuda Y, Ajimizu H, Yamazoe M, Kuninaga K, Ogimoto T, Hosoya K, Itotani R, Sakamori Y, Kim YH, Hirai T.
Yoshida H, et al. Among authors: kim yh.
Eur J Cancer. 2021 Feb;144:317-325. doi: 10.1016/j.ejca.2020.11.035. Epub 2020 Dec 30.
Eur J Cancer. 2021.
PMID: 33385948